Qiagen (QGEN) Convertible Debt (2020 - 2021)

Qiagen (QGEN) posted Convertible Debt of $445.9 million for Q4 2021, little changed sequentially from $445.9 million in Q4 2020, and little changed YoY from $445.9 million in Q4 2020.

Qiagen (QGEN) Convertible Debt (2020 - 2021) Analysis & Trends

Qiagen has reported Convertible Debt for 2 years, with the latest figure at $445.9 million in Q4 2021.

  • Quarterly Convertible Debt changed 0.0% year-over-year to $445.9 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $445.9 million (changed 0.0% YoY) and the FY2021 annual result came in at $445.9 million, changed 0.0% from the prior year.
  • Convertible Debt was little changed at $445.9 million in Q4 2021 per QGEN's latest filing, from $445.9 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $445.9 million in Q4 2020 and troughed at $445.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn
10 Qiagen 8.65 Bn 8.65 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2021 445.90 Mn
Dec 31, 2020 445.90 Mn